Liver Disease
Conference Coverage
Multiple therapies for NAFLD and NASH are now in phase 3 clinical trials
WASHINGTON – The trials are tricky, but these much-needed therapies may get conditional approval through reduction of liver inflammation and...
Video
NAFLD patients with abnormal liver tests may not get statins when indicated
WASHINGTON – Abnormal liver tests can make providers hesitant to start statins in NAFLD patients.
Conference Coverage
Percutaneous procedure gives alternative to anticoagulation for portal vein thrombosis
WASHINGTON – A transjugular intrahepatic portosystemic shunt is a feasible alternative to long-term anticoagulation for treating patients with...
From the Journals
Mediterranean diet cut fatty liver risk
The odds of new-onset fatty liver fell by 26% with each 1-standard deviation increase in Mediterranean-style diet score.
From the Journals
Scoring system quantified chances of HCV treatment benefit
Does a new scoring system hold the promise of avoiding 'MELD purgatory'?
From the Journals
Study eyes liver transplantation after Region 5 UNOS downstaging
An estimated 87% of downstaged patients were alive and recurrence free 5 years after transplantation.
Conference Coverage
Liver transplantation is on the rise for patients with severe alcoholic hepatitis
Traditional treatment of severe alcoholic hepatitis left many patients without a treatment option. But now more clinics are performing liver...
From the Journals
Alcohol abuse untreated in HCV patients, including HIV coinfected
HCV patients with alcohol-use disorder often don’t get the treatment they need.
News from the FDA/CDC
FDA approves Doptelet for liver disease patients undergoing procedures
Avatrombopag (Doptelet) is the first drug approved for thrombocytopenia in adults who have chronic liver disease and are undergoing a procedure....
Conference Coverage
Where the latest HCV drug combos fit in
MAUI, HAWAII – The biggest remaining challenge in the treatment of hepatitis C is to gain improved access to therapy, according to Steven L. Flamm...